Published in Strahlenther Onkol on March 01, 2014
Neoadjuvant treatment for unresectable rectal cancer: an interim analysis of a multicentre randomized study. Radiother Oncol (2013) 1.50
Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol (2000) 3.24
Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer (1988) 2.11
Rectal cancer : when is the local recurrence risk low enough to refrain from the aim to prevent it? Strahlenther Onkol (2013) 2.06
Sequences of pituitary and placental lactogenic and growth hormones: evolution from a primordial peptide by gene reduplication. Proc Natl Acad Sci U S A (1971) 2.04
[S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol (2004) 2.03
Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Int J Radiat Oncol Biol Phys (1995) 1.87
[Update S3-guideline "colorectal cancer" 2008]. Z Gastroenterol (2008) 1.81
The amino acid sequence of bovine parathyroid hormone I. Hoppe Seylers Z Physiol Chem (1970) 1.75
[S3-guideline colorectal cancer version 1.0]. Z Gastroenterol (2013) 1.51
Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone. Proc Natl Acad Sci U S A (1971) 1.50
[Asthma therapy in children and adults. Recommendations of the German Respiratory League of the German Society of Pneumology]. Med Klin (Munich) (1998) 1.47
[Adjuvant and neoadjuvant therapy of rectal carcinoma. The current status]. Strahlenther Onkol (1998) 1.45
Concerning the final report "Hyperthermia: a systematic review" of the Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, March 2010. Strahlenther Onkol (2012) 1.45
Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System. Clin Endocrinol (Oxf) (2007) 1.42
[Simultaneous radiochemotherapy with cisplatin improves survival in cervical cancer]. Strahlenther Onkol (1999) 1.41
Prevention of heterotopic ossification (HO) after total hip replacement: randomized high versus low dose radiotherapy. Radiother Oncol (1993) 1.41
[Combination of asthma and COPD: more frequent as considered to be?]. Pneumologie (2006) 1.40
High-dose intravascular beta-radiation after de novo stent implantation induces coronary artery spasm. Circulation (2002) 1.39
[Established combinations of inhaled corticoids and long-acting beta 2-symphathomimetics for long-term therapy of bronchial asthma. Position of an expert panel study]. Pneumologie (1999) 1.38
[Curative therapy in the presence of distant metastases. On the paper by H. Hawighorst et al. Cure in a patient with multiple osseus metastases in non-small cell lung cancer: a case report]. Strahlenther Onkol (1994) 1.38
Radiotherapy alone or radiochemotherapy with platin derivatives following transurethral resection of the bladder. Organ preservation and survival after treatment of bladder cancer. Strahlenther Onkol (1998) 1.38
DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol (2013) 1.32
The N-terminal amino acid sequence of two avian leukosis group specific antigens. Proc Natl Acad Sci U S A (1970) 1.31
Isolation of a second avian leukosis group-specific antigen (gs-b) from avian myeloblastosis virus. Proc Natl Acad Sci U S A (1970) 1.25
S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII). Z Gastroenterol (2010) 1.20
Radiation therapy as local treatment in Ewing's sarcoma. Results of the Cooperative Ewing's Sarcoma Studies CESS 81 and CESS 86. Cancer (1991) 1.18
[Therapy pf cervical lymph node metastases of unknown primary tumor]. Strahlenther Onkol (1997) 1.12
[Radiation therapy combined with local hyperthermia: a preliminary report of clinical experiences (author's transl)]. Strahlentherapie (1980) 1.10
Radiobiological mechanisms in inflammatory diseases of low-dose radiation therapy. Int J Radiat Biol (2007) 1.09
Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation. Int J Radiat Oncol Biol Phys (2000) 1.07
[Organ-preserving therapy in invasive bladder carcinoma]. Dtsch Med Wochenschr (1992) 1.06
The influence of supportive nutritional therapy via percutaneous endoscopically guided gastrostomy on the quality of life of cancer patients. Support Care Cancer (1993) 1.04
Transoral laser surgery of supraglottic cancer: follow-up of 141 patients. Arch Otolaryngol Head Neck Surg (1998) 1.03
Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer. Strahlenther Onkol (2000) 1.02
Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer. Radiother Oncol (1998) 1.02
Radiation therapy of optico-hypothalamic gliomas (OHG)--radiographic response, vision and late toxicity. Radiother Oncol (2000) 1.02
Neuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients. Int J Cancer (2014) 1.01
Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy. Int J Radiat Oncol Biol Phys (1997) 1.00
DEGRO practical guidelines: radiotherapy of breast cancer III--radiotherapy of the lymphatic pathways. Strahlenther Onkol (2014) 0.99
Fluorine-19 NMR spectroscopic studies of the metabolism of 5-fluorouracil in the liver of patients undergoing chemotherapy. Magn Reson Imaging (1987) 0.99
Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience. Int J Radiat Oncol Biol Phys (1999) 0.98
High frequency of spontaneous translocations revealed by FISH in cells from patients with the cancer-prone syndromes ataxia telangiectasia and Nijmegen breakage syndrome. Cytogenet Cell Genet (2001) 0.98
Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum (2000) 0.98
[Recommendations for asthma therapy in children and adults]. Pneumologie (1998) 0.97
[Radiotherapy of osteoarthritis. Indication, technique and clinical results]. Orthopade (2004) 0.96
One life saved by four prevented recurrences? Update of the Early Breast Cancer Trialists confirms: postoperative radiotherapy improves survival after breast conserving surgery. Strahlenther Onkol (2012) 0.95
Organ-sparing treatment of advanced bladder cancer: a 10-year experience. Int J Radiat Oncol Biol Phys (1994) 0.94
Binding of [3H]MSX-2 (3-(3-hydroxypropyl)-7-methyl-8-(m-methoxystyryl)-1-propargylxanthine) to rat striatal membranes--a new, selective antagonist radioligand for A(2A) adenosine receptors. Eur J Pharm Sci (2000) 0.92
DEGRO practical guidelines: radiotherapy of breast cancer II: radiotherapy of non-invasive neoplasia of the breast. Strahlenther Onkol (2014) 0.91
Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission : results of a multivariate analysis. Strahlenther Onkol (2012) 0.91
Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation. Int J Radiat Biol (2004) 0.90
Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer. Int J Radiat Oncol Biol Phys (2000) 0.89
Radiochemotherapy for bladder cancer. Clin Oncol (R Coll Radiol) (2009) 0.88
Amniotic membrane transplantation for persistent corneal epithelial defects in eyes after penetrating keratoplasty. Eye (Lond) (2008) 0.88
[Radiotherapy of plantar heel spurs: indications, technique, clinical results at different dose concepts]. Strahlenther Onkol (1996) 0.88
Percutaneous endoscopically guided gastrostomy in patients with head and neck cancer. Recent Results Cancer Res (1991) 0.88
Supratentorial low-grade glioma: results and prognostic factors following postoperative radiotherapy. Strahlenther Onkol (2000) 0.87
Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys (2000) 0.87
Early results of pulsed-dose-rate interstitial brachytherapy for head and neck malignancies after limited surgery. Int J Radiat Oncol Biol Phys (2000) 0.87
Heel spur: radiation therapy for refractory pain--results with three treatment concepts. Radiology (1996) 0.87
Invasive bladder cancer: organ preservation by radiochemotherapy. Front Radiat Ther Oncol (2002) 0.86
In vitro apoptosis in peripheral blood mononuclear cells induced by low-dose radiotherapy displays a discontinuous dose-dependence. Int J Radiat Biol (1999) 0.85
Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy? Statement of the German and the Austrian Societies of Radiooncology (DEGRO/ÖGRO). Strahlenther Onkol (2013) 0.85
Comparison of the accuracy of liver scans and peritoneoscopy in benign and malignant primary and metastasic tumours of the liver. 222 confirmed cases examined by both methods simultaneously. Scand J Gastroenterol (1973) 0.85
Synthesis, purification, and chemical characterization of the amino-terminal 1-34 fragment of bovine parathyroid hormone synthesized by the solid-phase procedure. Biochemistry (1977) 0.85
Anti-inflammatory effect of low-dose X-irradiation and the involvement of a TGF-beta1-induced down-regulation of leukocyte/endothelial cell adhesion. Int J Radiat Biol (2002) 0.85
c-erbB2 expression in correlation to other biological parameters of breast cancer. J Cancer Res Clin Oncol (1990) 0.85
Eight-year results of a prospective non-randomised study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG). Eur J Cancer (1998) 0.84
Sphincter preservation with chemoradiation in anal canal carcinoma: abdominoperineal resection in selected cases? Dis Colon Rectum (1998) 0.84
Radiation therapy after breast-conserving surgery; first results of a randomised clinical trial in patients with low risk of recurrence. Eur J Cancer (2004) 0.83
[S3-guideline conference "Colorectal Cancer" 2004]. Dtsch Med Wochenschr (2005) 0.83
Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy. Semin Surg Oncol (2001) 0.83
Biological rationales and clinical applications of temperature controlled hyperthermia--implications for multimodal cancer treatments. Curr Med Chem (2010) 0.82
Perioperative radiotherapy and concurrent radiochemotherapy in rectal cancer. Semin Surg Oncol (2001) 0.82
Adjuvant radiotherapy for breast carcinoma in men: a 20-year clinical experience. Am J Clin Oncol (1996) 0.82
[Radiotherapy of early stage Dupuytren disease. Long-term results after a median follow-up period of 10 years]. Strahlenther Onkol (2001) 0.82
Preoperative versus postoperative radiotherapy for prevention of heterotopic ossification (HO): first results of a randomized trial in high-risk patients. Int J Radiat Oncol Biol Phys (1994) 0.82
[Radiotherapy for painful degenerative joint disorders. Indications, technique and clinical results]. Strahlenther Onkol (1998) 0.81
Motor effects induced by a blockade of adenosine A2A receptors in the caudate-putamen. Neuroreport (1998) 0.81
Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997. Strahlenther Onkol (2001) 0.81
Prophylactic radiation therapy for prevention of heterotopic ossification after hip arthroplasty: results in 141 high-risk hips. Radiology (1993) 0.81
[Pretherapeutic evaluation of bone matastases in patients with potentially curable breast cancer (author's transl)]. Radiol Clin (Basel) (1975) 0.81
[The role of radiotherapy in the treatment of desmoid tumors]. Strahlenther Onkol (1993) 0.81
[Treatment of pathologic fractures]. Chirurg (1976) 0.81
When are breast cancer patients old enough for the quitclaim of local control? Strahlenther Onkol (2012) 0.81
Interstitial thermoradiotherapy: review on technical and clinical aspects. Am J Clin Oncol (1990) 0.81
Total lymphoid irradiation in patients with refractory rheumatoid arthritis. Arthritis Rheum (1985) 0.81
[Pre- and postoperative radiotherapy to prevent heterotopic ossification of the hip joint]. Strahlenther Onkol (1994) 0.80
[Partial breast irradiation for early breast cancer with favorable prognostic factors: 3-year results of the German-Austrian phase II-trial]. Rofo (2005) 0.80
How nescience may obscure evidence. Strahlenther Onkol (2014) 0.80
[Locally recurrent and metastatic malignant melanoma. Long-term results and prognostic factors after percutaneous radiotherapy]. Strahlenther Onkol (1999) 0.80
Multivariate analysis of prognostic parameters using interstitial thermoradiotherapy (IHT-IRT): tumor and treatment variables predict outcome. Int J Radiat Oncol Biol Phys (1994) 0.80
[The Cooperative Ewing Sarcoma Study CESS 81 of the German Pediatric Oncology Society--analysis after 4 years]. Klin Padiatr (1985) 0.80
[Dealing with cancer--conversations with radiotherapy patients]. Strahlenther Onkol (1988) 0.80
[Vascularization of free myocutaneous gracilis flaps in replacement transplantation after preoperative radiotherapy. An experimental study]. Strahlenther Onkol (2000) 0.80
Neuro-rhinosurgical treatment of aesthesioneuroblastoma. Acta Neurochir (Wien) (1989) 0.79
Neoadjuvant radio-chemotherapy in advanced primarilynon-resectable carcinomas of the pancreas. Eur J Surg Oncol (2000) 0.79
Guideline for the clinical application, documentation and analysis of clinical studies for regional deep hyperthermia: quality management in regional deep hyperthermia. Strahlenther Onkol (2012) 0.79
Smooth pursuit eye movements in schizophrenia and affective disorder. Psychol Med (1997) 0.79